Most recent by Maya Barghash, MD
SPONSORED CONTENT
December 13, 2022
4 min read
Save
FDA panel declines to support approval of omecamtiv mecarbil
An FDA advisory committee voted 8-3 against supporting the approval of the HF drug omecamtiv mecarbil, with panelists citing a small observed benefit for a limited group of patients.